1. Home
  2. CDZI vs PROK Comparison

CDZI vs PROK Comparison

Compare CDZI & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CDZI

CADIZ Inc.

HOLD

Current Price

$3.01

Market Cap

342.2M

Sector

Utilities

ML Signal

HOLD

Logo ProKidney Corp.

PROK

ProKidney Corp.

HOLD

Current Price

$1.54

Market Cap

316.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDZI
PROK
Founded
1983
2015
Country
United States
United States
Employees
31
N/A
Industry
Water Supply
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
342.2M
316.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CDZI
PROK
Price
$3.01
$1.54
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$7.40
AVG Volume (30 Days)
1.3M
1.1M
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$893,000.00
Revenue This Year
$12.97
N/A
Revenue Next Year
$102.40
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1075.00
52 Week Low
$2.87
$1.45
52 Week High
$6.96
$3.55

Technical Indicators

Market Signals
Indicator
CDZI
PROK
Relative Strength Index (RSI) 35.92 40.15
Support Level N/A $1.51
Resistance Level $5.08 $2.59
Average True Range (ATR) 0.24 0.08
MACD -0.03 -0.00
Stochastic Oscillator 20.41 34.88

Price Performance

Historical Comparison
CDZI
PROK

About CDZI CADIZ Inc.

Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, generating maximum revenue engaged in providing water filtration solutions for impaired or contaminated groundwater sources.

About PROK ProKidney Corp.

ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.

Share on Social Networks: